Cyclophosphamide, Docetaxel, Epirubicin, Nab-paclitaxel, and Paclitaxel Combination Regimen

The provided search results indicate that the exact 5-drug combination of cyclophosphamide, docetaxel, epirubicin, nab-paclitaxel, and paclitaxel is not a standard, single regimen used together. Instead, these drugs are commonly used in various two- or three-drug combinations, primarily for breast cancer treatment. Examples include: * **Docetaxel and cyclophosphamide (TC)**: Used as adjuvant therapy for breast cancer. * **Nab-paclitaxel followed by epirubicin/cyclophosphamide (EC)**: Used as neoadjuvant chemotherapy for triple-negative breast cancer. * **Nab-paclitaxel plus cyclophosphamide plus trastuzumab (AbraC-HER)**: Used as neoadjuvant treatment for HER2-positive breast cancer. These drugs are typically administered intravenously in cycles, with rest periods to allow recovery. They work by destroying rapidly dividing cells, such as cancer cells. Common side effects can include polyneuropathy, hematotoxicity, and allergic reactions, with severity varying between different combinations.